CEDAX

LOE Approaching

ceftibuten dihydrate

NDAORALFOR SUSPENSION

Approved

Dec 1995

Lifecycle

LOE Approaching

Competitive Pressure

30/100

Mechanism of Action

CLINICAL PHARMACOLOGY PHARMACOKINETICS Absorption CEDAX CAPSULES Ceftibuten is rapidly absorbed after oral administration of CEDAX Capsules. The plasma concentrations and pharmacokinetic parameters of ceftibuten after a single 400-mg dose of CEDAX Capsules to 12 healthy adult male volunteers (20 to…

Indications (1)

individuals with mild-to-moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below (see

External Resources

DailyMed

Full prescribing information

FDA Drugs@FDA

FDA approval history

RxNorm

Drug nomenclature & identifiers